Treatment with Evrysdi (risdiplam) improved motor function and quality of life in children and adults with spinal muscular atrophy (SMA), a real-world study in Hong Kong shows. The findings, from 34 patients followed for up to three years, showed clinically meaningful gains in motor and upper-limb function, particularly in treatment-naïve patients, along with a generally favorable […] The post Evrysdi boosts motor function, quality of life in Asian SMA patients appeared first on SMA News Today .

Source: https://smanewstoday.com/news/evrysdi-boosts-motor-function-quality-life-asian-sma-patients/ (Wed, 15 Apr 2026)

Ingested by the SMA platform's daily smanewstoday.com RSS pipeline. Cross-linked to our knowledge graph via the news auto-scoring cron.